Gene Therapy Market Research Reports & Industry Analysis

Publications found: 53

Sort by:

Gene Therapy Market Report by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, and Others), Vector Type (Viral Vector, Non-Viral Techniques), Delivery Method (In-Vivo Gene Therapy, Ex-Vivo Gene Therapy), Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032

US$ 2,999.00

The global gene therapy market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.8 Billion by 2032, exhibiting a growth rate (CAGR) of 13.9% during...

July 2024 136 pages

Viral Vector Manufacturing Market Report by Type (Adenoviral Vectors, Adeno-associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, and Others), Disease (Cancer, Genetic Disorders, Infectious Diseases, and Others), Application (Gene Therapy, Vaccinology), End User (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), and Region 2024-2032

US$ 2,999.00

The global viral vector manufacturing market size reached US$ 1,200.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 7,681.6 Million by 2032, exhibiting a growth rate (C...

July 2024 138 pages

Cell and Gene Therapies in Rare Disorders Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2026-2036

US$ 4,900.00

Cell and gene therapies in rare disorders represent a groundbreaking approach to treating genetic diseases that have traditionally lacked effective treatments. These therapies work by modifying a pati...

August 2026 -